College of Medicine, Medical University of South Carolina, 10 McClennan Banks Drive, SJCH 2190/MSC 918, Charleston, SC, 29425, USA.
Department of Surgery, Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC, USA.
Pediatr Surg Int. 2022 Jul;38(7):985-991. doi: 10.1007/s00383-022-05140-z. Epub 2022 May 20.
This study tested the hypothesis that complication accrual during pediatric extracorporeal life support (ECLS) increases mortality irrespective of indication for support.
Prospectively collected Extracorporeal Life Support Organization (ELSO) registry data for all neonatal and pediatric patients cannulated for ECLS at our institution from 1/1/2015 to 12/31/2020 was stratified based on the presence or absence of complications. We excluded renal replacement therapy from complications, as this is frequently and empirically applied within our practice.
Of 114 patients, overall survival to discharge was 66%. 62 patients (54%) had 149 total complications: 29% were mechanical (circuit related), and the rest were patient related. Age (neonatal versus pediatric), sex, race/ethnicity, support type, presence of pre-ECLS arrest, pre-ECLS pH and intubation-to-ECLS duration were not significantly associated with the development of complications. Patients with complications required longer ECLS duration (168 versus 86 median hours, p < 0.001) and were more likely to be decannulated due to death or poor prognosis (25% versus 8%, p = 0.022). One or more ECLS complications was associated with significantly decreased survival by Cox proportional hazard regression (p = 0.003).
Complications on ECLS are associated with longer support duration and predict decreased survival independent of pre-ECLS variables, suggesting a multidisciplinary ECLS team target for improved outcomes.
本研究旨在验证一个假说,即在儿科体外生命支持(ECLS)过程中并发症的发生会增加死亡率,而与支持的适应证无关。
从 2015 年 1 月 1 日至 2020 年 12 月 31 日,对在我院接受 ECLS 治疗的所有新生儿和儿科患者进行前瞻性收集,根据是否存在并发症将其分为两组。我们将肾脏替代治疗排除在并发症之外,因为在我们的实践中,这种治疗方法经常被广泛应用。
在 114 名患者中,出院时的总体生存率为 66%。62 名患者(54%)发生了 149 种并发症:29%为机械性(与回路相关),其余为患者相关。年龄(新生儿与儿科)、性别、种族/民族、支持类型、ECLS 前是否存在停搏、ECLS 前 pH 值和插管至 ECLS 开始时间与并发症的发生无显著相关性。发生并发症的患者需要更长的 ECLS 持续时间(168 小时与 86 小时中位数,p<0.001),且因死亡或预后不良而更有可能被拔管(25%与 8%,p=0.022)。多因素 Cox 比例风险回归分析显示,ECLS 并发症与生存率显著降低相关(p=0.003)。
ECLS 并发症与支持时间延长相关,并可预测生存率降低,与 ECLS 前的变量无关,这表明多学科 ECLS 团队应将改善预后作为目标。